C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter C—Drugs: GeneralPart 211—Current Good Manufacturing Practice for Finished PharmaceuticalsSubpart E—Control of Components and Drug Product Containers and Closures

21 C.F.R. § 211.80 (2026)

General requirements

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1981–2024 6citing cases
At a glance

Courts have cited this section in 6 opinions since 1981, 1 of them in the last five years. The most litigated part is subsection (a) (1 case).

(a) There shall be written procedures describing in sufficient detail the receipt, identification, storage, handling, sampling, testing, and approval or rejection of components and drug product containers and closures; such written procedures shall be followed.

(b) Components and drug product containers and closures shall at all times be handled and stored in a manner to prevent contamination.

(c) Bagged or boxed components of drug product containers, or closures shall be stored off the floor and suitably spaced to permit cleaning and inspection.

(d) Each container or grouping of containers for components or drug product containers, or closures shall be identified with a distinctive code for each lot in each shipment received. This code shall be used in recording the disposition of each lot. Each lot shall be appropriately identified as to its status (i.e., quarantined, approved, or rejected).

The 6 cases that cite 21 C.F.R. § 211.80 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENUnited States v. Radix Labs., Inc., 963 F.2d 1034 (7th Cir. 1992).
cites § 211.80 1×subsections: (a)cited by 14 cases
Where it cites § 211.80
“§ 351 (a)(2)(B); see also 21 C.F.R. 211.80(a) and 211.184. Tracking was impossible at the Esmond Road plant since production records did not exist.”
Later courts cite it for
“witness statements in the possession of the united states which relate to the subject matter as to which the witness testifies shall be turned over to the defendant for examination and use.” · 2 citing courts
2
cites § 211.80 1×cited by 13 cases
Where it cites § 211.80
“21 C.F.R. § 211.80 (a) (1983). 34 . See Administrative Record, Comments of NAP and NAPM, pp.”
Later courts cite it for
“sufficiently definite and precise to comport with constitutional standards and are not arbitrary or capricious on grounds of vagueness.” · 2 citing courts
3
GREENUnited States v. Richlyn Labs., Inc., 827 F. Supp. 1145 (E.D. Pa. 1992).
cites § 211.80 1×cited by 12 cases
Where it cites § 211.80
“See Generally: 21 C.F.R. §§ 211.80 , 211.100, 211.101, 211.”
Later courts cite it for
“indeed, because congress has seen fit to act in a given area by enacting a statute, irreparable injury must be presumed in a statutory enforcement action.” · 2 citing courts
4
GREENUnited States v. Richlyn Labs., Inc., 822 F. Supp. 268 (E.D. Pa. 1993).
cites § 211.80 1×cited by 6 cases
Where it cites § 211.80
“See Generally: 21 C.F.R. §§ 211.80 , 211.100, 211.101, 211.”
5
GREENUnited States v. Jamieson-McKames Pharm., Inc., 651 F.2d 532 (8th Cir. 1981).
cites § 211.80 1×cited by 25 cases
Where it cites § 211.80
“Specifically, 21 C.F.R. § 211.80 describes proper record-keeping procedures for packaging and labeling operations.”
Later courts cite it for
“virtually every phase of the drug industry is heavily regulated, from packaging, labeling, and certification of expiration dates, to prior fda approval before new drugs can be marketed.” · 2 citing courts
6
NO FLAGUnited States v. Merck KGaA, No. 1:21-cv-10866 (D. Mass. Mar. 15, 2024).
cites § 211.80 2×cited by 0 casesunknown
Where it cites § 211.80
“See 21 C.F.R. § 211.80 . These regulations require, inter alia, that “[c]omponents and drug product containers and closures shall at all times be handled and stored in a manner to prevent contamination.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
198120022024

One bar per year. Tallest: 2 cases in 1992. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
E.D. Pa.27th Cir.18th Cir.1D. Mass.1S.D.N.Y.1
By subsection
(a)1 case
United States v. Radix Labs., Inc., 963 F.2d 1034 (7th Cir. 1992).“§ 351 (a)(2)(B); see also 21 C.F.R. 211.80(a) and 211.184. Tracking was impossible at the Esmond Road plant since production records did not exist.”
Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com